Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
AP-1 complex subunit gamma-like 2 (AP1G2) is a large subunit of the adaptor protein complex 1 (AP-1), which functions predominantly in vesicle trafficking between the trans-Golgi network, endosomes, and the plasma membrane. AP1G2 is a gamma-adaptin family protein that participates in the formation of clathrin-coated vesicles and is crucial for the proper sorting and delivery of membrane proteins. The AP-1 complex is a heterotetramer consisting of two large (gamma, beta1), one medium (mu1), and one small (sigma1) subunit. AP1G2 provides unique gamma-2 adaptin functionality to certain AP-1 complexes, possibly mediating specialized trafficking roles or regulation in mammalian cells. It is involved in protein sorting in late endosomes and multivesicular bodies, including interactions with ESCRT machinery components. While AP1G2 is crucial for cellular physiology, especially for vesicle transport, it is not currently a therapeutic target and has no direct disease or drug associations
Not applicable; no drugs are known to target this protein, so mechanisms of drug action regarding AP1G2 are not described.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on AP-1 complex subunit gamma-like 2 (AP1G2).